<DOC>
	<DOCNO>NCT01400854</DOCNO>
	<brief_summary>Aim non-interventional study investigate tolerability Effentora® cancer pain patient breakthrough pain real-life condition clinical practice .</brief_summary>
	<brief_title>Effentora® Clinical Practice - Non-interventional Study Evaluate Satisfaction Tolerability</brief_title>
	<detailed_description>In addition effectiveness Effentora® therapy , safety , general feasibility impact therapy patient ' quality life interest .</detailed_description>
	<criteria>decision start treatment Effentora prescription accordance Summary Product Characteristics ( SmPC ) personally sign date Informed Consent document subject consider unsuitable accord SmPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>breakthrough cancer pain</keyword>
</DOC>